• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID Back to Search Results
Model Number 26605
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/25/2020
Event Type  malfunction  
Event Description
It was reported that reported that the stent partially deployed.The target lesion was located in the highly tortuous right internal carotid artery (ica).An 8.0-36 carotid wallstent was selected for the procedure.During the procedure, the stent was advanced and stent deployment was initiated.However, stent deployment stopped after the 80% of the stent opened.There was a click observed in the catheter and it was impossible to fully open the stent.The entire delivery system and stent were able to be pulled back and removed.The procedure was completed with another device.There were no patient complications and the patient status was stable post procedure.
 
Manufacturer Narrative
Device evaluated by manufacturer: the returned device consisted of carotid monorail.The device was received with the stent in the correct position on the delivery system.The stent could not be deployed due to a complete break in the outer shaft of the device and solidified media inside the delivery system.A visual and tactile inspection of the catheter identified a complete break of the outer shaft located approximately 30mm distal of the main valve.This type of damage is consistent with excessive force being applied to the device.A visual and tactile examination identified no issues with the tip of the device.Inspection of the remainder of the device, apart from the observed damage revealed no other damage or irregularities.
 
Event Description
It was reported that reported that the stent partially deployed.The target lesion was located in the highly tortuous right internal carotid artery (ica).An 8.0-36 carotid wallstent was selected for the procedure.During the procedure, the stent was advanced and stent deployment was initiated.However, stent deployment stopped after the 80% of the stent opened.There was a click observed in the catheter and it was impossible to fully open the stent.The entire delivery system and stent were able to be pulled back and removed.The procedure was completed with another device.There were no patient complications and the patient status was stable post procedure.It was further reported that the 60% stenosed target lesion was located in the and highly calcified and very tortuous right ica.It was a tough stenosis and not easy to pass.The stent was fully reconstrained without issue after the deployment failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAROTID WALLSTENT
Type of Device
STENT, CAROTID
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10650859
MDR Text Key210463585
Report Number2134265-2020-13871
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 11/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/29/2023
Device Model Number26605
Device Catalogue Number26605
Device Lot Number0024847133
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/12/2020
Initial Date Manufacturer Received 09/28/2020
Initial Date FDA Received10/08/2020
Supplement Dates Manufacturer Received10/08/2020
Supplement Dates FDA Received11/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age75 YR
-
-